Compugen Ltd

Compugen Ltd

CGEN

Market Cap$138.4M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Compugen LtdCompugen Ltd-9.3-3%-0.2
$2.54

Current Fair Value

97.1% upside

Undervalued by 97.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$138.40 Million
Enterprise Value$132.71 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.16
Beta3.2
Outstanding Shares89,538,891

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-9.31
PEG8.24
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue2.22
Enterprise Value to EBIT12.55
Enterprise Value to Net Income82
Total Debt to Enterprise0.09
Debt to Equity0.23

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Compugen Ltd

CEO: Anat Cohen-Dayag

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immu...